Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

Jeffrey Conn, P., Christopoulos, Arthur, Lindsley, Craig W.·2009·Nature Reviews Drug Discovery

DOI 10.1038/nrd2760

Cited by (1,000)

Items 501–600 of 1,000

PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia.
Michael G R Beyaert, Ritesh P. Daya, Bailey A. Dyck, Rodney L. Johnson, R. Mishra · 2013 · European Neuropsychopharmacology
GABAB Receptor-Positive Modulators: Enhancement of GABAB Receptor Agonist Effects In Vivo
Wouter Koek, Charles Patrick France, Kejun Cheng, Kenner C. Rice · 2010 · Journal of Pharmacology and Experimental Therapeutics
The Therapeutic Potential of Allosteric Ligands for Free Fatty Acid Sensitive GPCRs
Brian D. Hudson, Trond Ulven, Graeme Milligan · 2013 · Current Topics in Medicinal Chemistry
In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor
Martyn D. Wood, Ali Ates, Véronique André, Anne Michel, Robert J. Barnaby, Michel R. Gillard · 2015 · Molecular Pharmacology
Functional Consequences of GPCR Heterodimerization: GPCRs as Allosteric Modulators
Karla Haack, Nael A. McCarty · 2011 · Pharmaceuticals
Balb/c mice treated with d-cycloserine arouse increased social interest in conspecifics
Andrew D. Benson, Jessica A. Burket, Stephen I. Deutsch · 2013 · Brain Research Bulletin
The potassium channel KcsA: A model protein in studying membrane protein oligomerization and stability of oligomeric assembly?
Mobeen Raja · 2011 · Archives of Biochemistry and Biophysics
Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor
Chang-Jiang Qiao, Hamed Ismail Ali, Kwang H. Ahn, Srikanth Kolluru, Debra A. Kendall, Dai Lu · 2016 · European Journal of Medicinal Chemistry
Ligand-guided homology modelling of the GABAB2 subunit of the GABAB receptor
T. Freyd, Dawid Warszycki, Stefan Mordalski, Andrzej Jacek Bojarski, Ingebrigt Sylte, Mari Gabrielsen · 2017 · PLoS ONE
Hippocampal place cell dysfunction and the effects of muscarinic M1 receptor agonism in a rat model of Alzheimer's disease
Claire R. Galloway, Kaushik Ravipati, Suyashi Singh, Evan P. Lebois, Robert M. Cohen, Allan I. Levey, Joseph R. Manns · 2018 · Hippocampus
Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics
Irene Fasciani, Francesco Petragnano, Gabriella Aloisi, Francesco Marampon, Marco Carli, Marco Scarselli, Roberto Maggio, Mario Rossi · 2020 · Pharmaceuticals
Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder
Eric Augier · 2021 · Alcohol and Alcoholism
New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type‐1 cannabinoid receptor (CB1R) activity and function
Pierre‐Louis Raux, Guillaume Drutel, Jean‐Michel Revest, Monique Vallée · 2021 · Journal of Neuroendocrinology
In silico identification of a β 2 -adrenoceptor allosteric site that selectively augments canonical β 2 AR-Gs signaling and function
Sushrut D. Shah, Christoffer Lind, Francesco De Pascali, Raymond B. Penn, Alexander D. MacKerell, Deepak A. Deshpande · 2022 · Proceedings of the National Academy of Sciences
Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery
Iashia Tur Razia, Ayesha Kanwal, Hafiza Fatima Riaz, Abbeha Malik, Muhammad Ahsan, Muhammad Saleem Khan, Ali Raza, Sumera Sabir, Zureesha Sajid, Muhammad Fardeen Khan et al. · 2023 · Current Topics in Medicinal Chemistry
Allosteric modulation of A1-adenosine receptor: a review
María Kimatrai-Salvador, Pier Giovanni Baraldi, Romeo Romagnoli · 2012 · Drug Discovery Today Technologies
Discovery of an orexin receptor positive potentiator
Jiyong Lee, M. Muralidhar Reddy, Thomas J. Kodadek · 2010 · Chemical Science
Identification of Amides as Carboxylic Acid Surrogates for Quinolizidinone-Based M1 Positive Allosteric Modulators
Scott D. Kuduk, Ronald K. Chang, Thomas J. Greshock, William J. Ray, Lei Ma, Marion Wittmann, Matthew A. Seager, Kenneth A. Koeplinger, Charles D. Thompson, George D. Hartman et al. · 2012 · ACS Medicinal Chemistry Letters
Therapeutic Potential of Targeting Metabotropic Glutamate Receptors for Parkinson’s Disease
Jonathan W. Dickerson, Peter Jeffrey Conn · 2012 · Neurodegenerative Disease Management
Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators
Iain R. Greig, Gemma L. Baillie, Mostafa Abdelrahman, Laurent Trembleau, Ruth A. Ross · 2016 · Bioorganic & Medicinal Chemistry Letters
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers
Carolina L. Haass‐Koffler, Kimberly Goodyear, Victoria M. Long, Harrison H. Tran, Antonella Loche, Roberto Cacciaglia, Robert M. Swift, Lorenzo Leggio · 2017 · European Journal of Pharmaceutical Sciences
In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease
Agostinho Lemos, Rita Melo, António J. Preto, José Guilherme de Almeida, Irina Sousa Moreira, M. Natália D. S. Cordeiro · 2018 · Current Neuropharmacology
Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors
Damiana Cavallo, Elisa Landucci, Elisabetta Gerace, Daniele Lana, Filippo Ugolini, Jeremy Martin Henley, Maria Grazia Giovannini, Domenico Edoardo Pellegrini-Giampietro · 2019 · Neuropharmacology
Molecular mechanism of the arrestin-biased agonism of neurotensin receptor 1 by an intracellular allosteric modulator
Demeng Sun, Xiang Li, Qingning Yuan, Yuanxia Wang, Pan Shi, Huanhuan Zhang, Tao Wang, Wenjing Sun, Shenglong Ling, Yuanchun Liu et al. · 2025 · Cell Research
Metabotropic Glutamate Receptor 5-positive Allosteric Modulators for the Treatment of Schizophrenia (2004–2012)
Craig W. Lindsley, Shaun R. Stauffer · 2012 · Pharmaceutical Patent Analyst
Down-regulation of PAR1 activity with a pHLIP-based allosteric antagonist induces cancer cell death
Kelly E. Burns, Damien Thévenin · 2015 · Biochemical Journal
The Effect of CB1 Antagonism on Hepatic Oxidative/Nitrosative Stress and Inflammation in Nonalcoholic Fatty Liver Disease
Bojan Z. Jorgačević, Danijela B. Vučević, Janko Samardžić, Dušan R. Mladenović, Milena N. Vesković, Dušan Vukićević, Rada Ješić, Tatjana S. Radosavljević · 2020 · Current Medicinal Chemistry
The unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligands
Jingjing Wang, Meng Wu, Zhangcheng Chen, Lijie Wu, Tian Wang, Dongmei Cao, Huan Wang, Shenhui Liu, Yueming Xu, Fei Li et al. · 2022 · Nature Communications
Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects
Gerald J. Mizejewski · 2011 · Cancers
Brazilin isolated from Caesalpinia sappan L. acts as a novel collagen receptor agonist in human platelets
Yi Fang Chang, Steven Kuan Hua Huang, Wan‐Jung Lu, Chi‐Li Chung, Wei Lin Chen, Shun Hua Lu, Kuan‐Hung Lin, Joen Rong Sheu · 2013 · Journal of Biomedical Science
Discovery of 1,5-Disubstituted Pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor
Jose Maria Cid, Guillaume Duvey, Philippe Cluzeau, Vanthea Nhem, Karim Macary, Alexandre Raux, Nicolas Poirier, Jessica Muller, Christelle Boléa, Terry Finn et al. · 2010 · ACS Chemical Neuroscience
Coupled Dynamics and Entropic Contribution to the Allosteric Mechanism of Pin1
Arghya Barman, Donald Hamelberg · 2016 · The Journal of Physical Chemistry B
Attenuation of neurodegenerative phenotypes in Alzheimer-like presenilin 1/presenilin 2 conditional double knockout mice by EUK1001, a promising derivative of xanomeline
Dong Wang, Liguo Yang, Jingjing Su, Yan Niu, Xiaoping Lei, Juan Xiong, Xiaohua Cao, Yinghe Hu, Bing Mei, Jin‐Feng Hu · 2011 · Biochemical and Biophysical Research Communications
Computational Analysis of Negative and Positive Allosteric Modulator Binding and Function in Metabotropic Glutamate Receptor 5 (In)Activation
James A. R. Dalton, Xavier Gómez‐Santacana, Amadeu Llebaria, Jesús Giraldo · 2014 · Journal of Chemical Information and Modeling
Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series
Scott D. Kuduk, Ronald K. Chang, Christina Ng Di Marco, William J. Ray, Lei Ma, Marion Wittmann, Matthew A. Seager, Kenneth A. Koeplinger, Charles D. Thompson, George D. Hartman et al. · 2011 · Bioorganic & Medicinal Chemistry Letters
Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor
Aditya J. Desai, Maoqing Dong, Kaleeckal G. Harikumar, Laurence J. Miller · 2016 · International Journal of Obesity Supplements
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization
Taha Azad, Ragunath Singaravelu, Mathieu J. F. Crupi, Taylor R. Jamieson, Jaahnavi Dave, Emily E.F. Fekete, Reza Rezaei, Zaid Taha, Stephen Boulton, Nikolas Tim Martin et al. · 2020 · Membranes
Heterocyclic fused pyridone carboxylic acid M1 positive allosteric modulators
Scott D. Kuduk, Christina Ng Di Marco, Ronald K. Chang, William J. Ray, Lei Ma, Marion Wittmann, Matthew A. Seager, Kenneth A. Koeplinger, Charles D. Thompson, George D. Hartman et al. · 2010 · Bioorganic & Medicinal Chemistry Letters
pocketZebra: a web-server for automated selection and classification of subfamily-specific binding sites by bioinformatic analysis of diverse protein families
Dmitry A. Suplatov, Evgeny M. Kirilin, Mikhail S. Arbatsky, Vakil Takhaveev, Vytas K. Švedas · 2014 · Nucleic Acids Research
Biasing the Prostaglandin F2α Receptor Responses toward EGFR-Dependent Transactivation of MAPK
Eugénie Goupil, Veronica Wisehart, Etienne Khoury, Brandon Zimmerman, Sahar Majdi Jaffal, Terence E. Hébert, Stéphane A. Laporte · 2012 · Molecular Endocrinology
Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu2/mGlu3 NAMs
Cody J. Wenthur, Ryan D. Morrison, John Scott Daniels, Peter Jeffrey Conn, Craig W. Lindsley · 2014 · Bioorganic & Medicinal Chemistry Letters
Toward Selective Drug Development for the Human 5-Hydroxytryptamine 1E Receptor: A Comparison of 5-Hydroxytryptamine 1E and 1F Receptor Structure-Affinity Relationships
Michael T. Klein, Maƚgorzata Dukat, Richard A. Glennon, Milt Teitler · 2011 · Journal of Pharmacology and Experimental Therapeutics
Odour perception: A review of an intricate signalling pathway
Anne Tromelin · 2015 · Flavour and Fragrance Journal
Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents
Paulina Cieślik, Monika Woźniak, Jerri M. Rook, Mohammed N. Tantawy, Peter Jeffrey Conn, Francine Acher, Krzysztof Tokarski, Magdalena Kusek, Andrzej Pilc, Joanna Monika Wierońska · 2018 · Psychopharmacology
The allosteric landscape of the Src kinase
Toni Beltran, Mohsin M. Naqvi, André J. Faure, Ben Lehner · 2026 · Science Advances
Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding
Scott D. Kuduk, Christina Ng Di Marco, Victoria Cofre, Daniel R. Pitts, William J. Ray, Lei Ma, Marion Wittmann, Matthew A. Seager, Kenneth A. Koeplinger, Chuck D. Thompson et al. · 2009 · Bioorganic & Medicinal Chemistry Letters
Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists
Cheryse A. Furman, Rebecca A. Roof, Amy E. Moritz, Brittney N. Miller, Trevor B. Doyle, R. Benjamin Free, Ashwini K. Banala, Noel M. Paul, Vivek Kumar, Christopher D. Sibley et al. · 2014 · European Neuropsychopharmacology
Characterization of the Ligand Receptor Encounter Complex and Its Potential for in Silico Kinetics-Based Drug Development
Karim M. ElSawy, Reidun Twarock, David Philip Lane, Chandra Shekhar Verma, Leo S. D. Caves · 2011 · Journal of Chemical Theory and Computation
Decoding Gαq signaling
Irene Litosch · 2016 · Life Sciences
Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core
Michael R. Wood, Meredith J. Noetzel, Julie L. Engers, Katrina A. Bollinger, Bruce J. Melancon, James Christopher Tarr, Changho Han, Mary K. West, Alison R. Gregro, Atin Lamsal et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In Vitro
Susanne Neumann, Elena Eliseeva, Alisa Boutin, Elena S. Barnaeva, Marc Ferrer, Noel T Southall, David S. Kim, Xin Hu, Sarah J. Morgan, Juan Marugán et al. · 2017 · Journal of Pharmacology and Experimental Therapeutics
Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M2R Affinity and Selectivity
Xueke She, Andrea Pegoli, Judith Mayr, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller · 2017 · ACS Omega
Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis
Susan F. Sonnenschein, Anthony A. Grace · 2020 · Expert Opinion on Therapeutic Targets
Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery
R. N. V. Krishna Deepak, Ravi Kumar Verma, Yossa Dwi Hartono, Wen Shan Yew, Hao Fan · 2021 · Pharmaceuticals
Conservation and Diversity in Allosteric Fingerprints of Proteins for Evolutionary-inspired Engineering and Design
Wei-Ven Tee, Zhen Wah Tan, Enrico Guarnera, Igor N. Berezovsky · 2022 · Journal of Molecular Biology
Photoswitchable allosteric modulators for metabotropic glutamate receptors
Xavier Gómez‐Santacana, Silvia Panarello, Xavier Rovira, Amadeu Llebaria · 2022 · Current Opinion in Pharmacology
5-HT2C Receptor Stimulation in Obesity Treatment: Orthosteric Agonists vs. Allosteric Modulators
Edmund Przegaliński, Kacper Witek, Karolina Wydra, Jolanta Helena Kotlinska, Małgorzata Filip · 2023 · Nutrients
Heterodimerization of the GABAB Receptor—Implications for GPCR Signaling and Drug Discovery
Fiona H. Marshall, Steven M. Foord · 2010 · Advances in pharmacology
G Protein-Coupled Receptor Transmembrane Binding Pockets and their Applications in GPCR Research and Drug Discovery: A Survey
Nicole A. Kratochwil, Silvia Gatti‐McArthur, Marius Christian Hoener, Lothar Lindemann, Andreas D. Christ, Luke G. Green, Wolfgang Guba, Rainer E. Martin, Pari Malherbe, Richard H. P. Porter et al. · 2011 · Current Topics in Medicinal Chemistry
Classification of GPCRs Using Family Specific Motifs
Murat Can Çobanoğlu, Yücel Saygın, Osman Uğur Sezerman · 2010 · IEEE Transactions on Computational Biology and Bioinformatics
The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors
Ravi Kumar Verma, Ara M. Abramyan, M. Michino, R. Free, David R. Sibley, J. Javitch, J. R. Lane, Lei Shi · 2018 · PLoS Comput. Biol.
Probing the binding site of novel selective positive allosteric modulators at the M1 muscarinic acetylcholine receptor
Elham Khajehali, Céline Valant, Manuela Jörg, Andrew B. Tobin, Peter Jeffrey Conn, Craig W. Lindsley, Patrick Michael Sexton, Peter J. Scammells, Arthur Christopoulos · 2018 · Biochemical Pharmacology
Identification of Selective Novel Hits against Plasmodium falciparum Prolyl tRNA Synthetase Active Site and a Predicted Allosteric Site Using In Silico Approaches
Dorothy Wavinya Nyamai, Özlem Taştan Bishop · 2020 · International Journal of Molecular Sciences
Editorial (Hot Topic: From Allosteric Drugs to Allo-Network Drugs: State of the Art and Trends of Design, Synthesis and Computational Methods)
Péter Csermely, Ruth Nussinov, András Szilágyi · 2013 · Current Topics in Medicinal Chemistry
Toward the Design of Allosteric Effectors: Gaining Comprehensive Control of Drug Properties and Actions
Wei-Ven Tee, Sylvester Jian Ming Lim, Igor N. Berezovsky · 2024 · Journal of Medicinal Chemistry
Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation
Danuta Jantas, A. Gręda, Monika Leśkiewicz, Beata Grygier, Andrzej Pilc, Władysław Lasoń · 2015 · Neurochemistry International
Subtleties in GPCR drug discovery: a medicinal chemistry perspective
Masahiko Fujioka, Naoki Omori · 2012 · Drug Discovery Today
Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor
R. M. Garbaccio, Edward J. Brnardic, Mark E. Fraley, George D. Hartman, Pete H. Hutson, Julie A. O’Brien, Brian C. Magliaro, Jason M. Uslaner, Sarah L. Huszar, Kerry L. Fillgrove et al. · 2010 · ACS Medicinal Chemistry Letters
Novel approaches to drug design for the treatment of schizophrenia
Antoine Taly · 2013 · Expert Opinion on Drug Discovery
Characteristics of Allosteric Proteins, Sites, and Modulators
Xinheng He, Duan Ni, Shaoyong Lu, Jian Zhang · 2019 · Advances in experimental medicine and biology
Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
Beatrice Polini, Chiara Cervetto, Sara Carpi, Simone Pelassa, Francesca Gado, Rebecca Ferrisi, Simone Bertini, Paola Nieri, Manuela Marcoli, Clementina Manera · 2020 · Life
Safety, pharmacokinetics and quantitative EEG modulation of TAK‐071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects
Wei Yin, Fahimeh Mamashli, Derek L. Buhl, Polyna Khudyakov, Dmitri Volfson, Ferenc Martényi, Hakop Gevorkyan, Laura B. Rosen, Arthur A. Simen · 2021 · British Journal of Clinical Pharmacology
Group III metabotropic glutamate receptors as promising targets for neuroprotective therapy: Particular emphasis on the role of mGlu4 and mGlu7 receptors
Helena Domin · 2022 · Pharmacology Biochemistry and Behavior
Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems
Georges Vauquelin, Isabelle Van Liefde · 2012 · Expert Opinion on Drug Discovery
M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease
Michael W. Decker, Ulrike Holzgrabe · 2012 · MedChemComm
Discovery of Naphthyl-Fused 5-Membered Lactams as a New Class of M1 Positive Allosteric Modulators
Zhiqiang Yang, Youheng Shu, Lei Ma, Marion Wittmann, William J. Ray, Matthew A. Seager, Kenneth A. Koeplinger, Charles D. Thompson, George D. Hartman, Mark T. Bilodeau et al. · 2014 · ACS Medicinal Chemistry Letters
Calcium-Mediated Control of S100 Proteins: Allosteric Communication via an Agitator/Signal Blocking Mechanism
Yiming Xiao, Gary S. Shaw, Lars Konermann · 2017 · Journal of the American Chemical Society
Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?
Hui Tao, Bo Yang, Atena Farhangian, Ke Xu, Tongtong Li, Zhong‐Yin Zhang, Jianing Li · 2025 · Journal of Medicinal Chemistry
QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators
Gary Tresadern, Jose Maria Cid, Andrés A. Trabanco · 2014 · Journal of Molecular Graphics and Modelling
Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target
David R. Janero, Ganesh A. Thakur · 2016 · Expert Opinion on Drug Discovery
Mechanisms Underlying Allosteric Molecular Switches of Metabotropic Glutamate Receptor 5
Claudia Llinás del Torrent, Nil Casajuana-Martín, Leonardo Pardo, Gary Tresadern, Laura Pérez‐Benito · 2019 · Journal of Chemical Information and Modeling
Drug discovery in the next decade: innovation needed ASAP
Youssef L. Bennani · 2011 · Drug Discovery Today
Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2
Brandon Wey-Hung Liauw, Arash Foroutan, Michael R Schamber, Weifeng Lu, Hamid Samareh Afsari, Reza Vafabakhsh · 2022 · eLife
Opportunities and challenges for the development of M 1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits
Huong T. M. Nguyen, Emma T. van der Westhuizen, Christopher J. Langmead, Andrew B. Tobin, Patrick Michael Sexton, Arthur Christopoulos, Céline Valant · 2022 · British Journal of Pharmacology
Targeting cryptic allosteric sites of G protein-coupled receptors as a novel strategy for biased drug discovery
Xin Qiao, Xiaolong Li, Mingyang Zhang, Ning Liu, Yanmei Wu, Shaoyong Lu, Ting Chen · 2025 · Pharmacological Research
Improved Glucose Metabolism In Vitro and In Vivo by an Allosteric Monoclonal Antibody That Increases Insulin Receptor Binding Affinity
John Corbin, Vinay Bhaskar, Ira D. Goldfine, Daniel Bedinger, Angela Lau, Kristen S. Michelson, Lisa M. Gross, Betty A. Maddux, Hua F. Kuan, Catarina Tran et al. · 2014 · PLoS ONE
Current Status of A1Adenosine Receptor Allosteric Enhancers
Romeo Romagnoli, Pier Giovanni Baraldi, Allan R. Moorman, Pier Andrea Borea, Katia Varani · 2015 · Future Medicinal Chemistry
Allosteric Modulation of Chemoattractant Receptors
Marcello Allegretti, Maria Candida Cesta, Massimo Locati · 2016 · Frontiers in Immunology
Targeting G protein-coupled receptors in cancer therapy
Surinder M. Soond, Andrey A. Zamyatnin · 2019 · Advances in cancer research
Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling
Gary Tresadern, Andrés A. Trabanco, Laura Pérez‐Benito, John P. Overington, Herman van Vlijmen, Gerard J. P. van Westen · 2017 · Journal of Chemical Information and Modeling
Allosteric Molecular Switches in Metabotropic Glutamate Receptors
Zoltán Orgován, György G. Ferenczy, György Miklós Keserű · 2020 · ChemMedChem
Role of Airway Smooth Muscle in Inflammation Related to Asthma and COPD
Hiroaki Kume · 2021 · Advances in experimental medicine and biology
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids
Thuy Nguyen, Thomas F. Gamage, Ann M. Decker, David B. Finlay, Tiffany L. Langston, Daniel G. Barrus, Michelle Glass, Danni L. Harris, Yanan Zhang · 2021 · Bioorganic & Medicinal Chemistry
M 1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease
Louis Dwomoh, Mario Rossi, Miriam Scarpa, Elham Khajehali, Colin Molloy, Pawel Herzyk, Shailesh N. Mistry, Andrew R. Bottrill, Patrick Michael Sexton, Arthur Christopoulos et al. · 2022 · Science Signaling
Therapeutic Potential of Ccr1 Antagonists for Multiple Myeloma
Angela R Karash, Annette Gilchrist · 2011 · Future Medicinal Chemistry
Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7
Anna Ehrlich, Paramita Ray, Kathryn E. Luker, Elias Lolis, Gary D. Luker · 2013 · Biochemical Pharmacology
Substituted 1-Phenyl-3-(pyridin-2-yl)urea Negative Allosteric Modulators of mGlu5: Discovery of a New Tool Compound VU0463841 with Activity in Rat Models of Cocaine Addiction
Russell Joseph Amato, Andrew S. Felts, Alice L. Rodriguez, Daryl F. Venable, Ryan D. Morrison, Frank W. Byers, John Scott Daniels, Colleen Marie Niswender, Peter Jeffrey Conn, Craig W. Lindsley et al. · 2013 · ACS Chemical Neuroscience
Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action
Paolo Gubellini, Christophe Melon, Elena Dale, Darı́o Doller, Lydia Kerkerian‐Le Goff · 2014 · Neuropharmacology
Discovery of novel mGluR1 antagonists: A multistep virtual screening approach based on an SVM model and a pharmacophore hypothesis significantly increases the hit rate and enrichment factor
Guo‐Bo Li, Lingling Yang, Shan Feng, Jian-Ping Zhou, Qi Huang, Huanzhang Xie, Linli Li, Shengyong Yang · 2011 · Bioorganic & Medicinal Chemistry Letters
ChAkt1 involvement in orchestrating the immune and heat shock responses in Crassostrea hongkongensis: Molecular cloning and functional characterization
Fuxuan Wang, Shu Xiao, Yang Zhang, Yuehuan Zhang, Ying Liu, Yan Yan, Zhiming Xiang, Ziniu Yu · 2015 · Fish & Shellfish Immunology